Get the Stockscreener App
1.19
3.48%
0.04
Pds Biotechnology Corporation stock is traded at $1.19, with a volume of 240.48K.
It is up +3.48% in the last 24 hours and up +3.48% over the past month.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
See More
Previous Close:
$1.15
Open:
$1.18
24h Volume:
240.48K
Relative Volume:
0.46
Market Cap:
$55.49M
Revenue:
-
Net Income/Loss:
$-40.56M
P/E Ratio:
-1.0171
EPS:
-1.17
Net Cash Flow:
$-35.28M
1W Performance:
+0.00%
1M Performance:
+3.48%
6M Performance:
-11.19%
1Y Performance:
-63.94%
1-Day Range:
$1.1507
$1.2299
1-Week Range:
$1.15
$1.25
52-Week Range:
$0.8505
$4.29
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Name
Pds Biotechnology Corporation
Sector
Industry
Phone
800-208-3343
Address
303A COLLEGE ROAD EAST, PRINCETON
Compare PDSB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
1.19 | 57.83M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-01-22 | Initiated | B. Riley Securities | Buy |
| Jun-28-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-10-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-27-20 | Initiated | Alliance Global Partners | Buy |
| Mar-09-20 | Initiated | Noble Capital Markets | Outperform |
| Oct-24-19 | Initiated | Chardan Capital Markets | Buy |
View All
Pds Biotechnology Corporation Stock (PDSB) Latest News
Trend analysis for PDS Biotechnology Corporation this weekJuly 2025 PreEarnings & Stock Portfolio Risk Control - Newser
Chart based analysis of PDS Biotechnology Corporation trendsPortfolio Value Summary & Weekly Market Pulse Updates - Newser
Short interest data insights for PDS Biotechnology CorporationJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - Newser
Market reaction to PDS Biotechnology Corporation’s recent newsRate Cut & High Return Trade Opportunity Guides - Newser
What the charts say about PDS Biotechnology Corporation todayMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
Can PDS Biotechnology Corporation recover in the next quarterSwing Trade & AI Driven Stock Price Forecasts - Newser
When is the best time to exit PDS Biotechnology CorporationJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - Newser
Will breakout in PDS Biotechnology Corporation lead to full recoveryMarket Movers & Safe Entry Trade Reports - Newser
Risk adjusted return profile for PDS Biotechnology Corporation analyzed2025 Market Trends & Technical Buy Zone Confirmation - Newser
What earnings revisions data tells us about PDS Biotechnology CorporationIPO Watch & Verified Technical Trade Signals - Newser
Can trapped investors hope for a rebound in PDS Biotechnology CorporationShort Setup & Safe Entry Momentum Stock Tips - Newser
Should you hold or exit PDS Biotechnology Corporation nowRisk Management & Consistent Profit Alerts - Newser
How to build a dashboard for PDS Biotechnology Corporation stockJuly 2025 Trade Ideas & Verified Short-Term Trading Plans - Newser
What does recent volatility data suggest for PDS Biotechnology Corporation2025 Biggest Moves & Precise Buy Zone Identification - Newser
What Fibonacci levels say about PDS Biotechnology Corporation rebound2025 Support & Resistance & Momentum Based Trading Signals - Newser
What institutional flow reveals about PDS Biotechnology CorporationJuly 2025 Big Picture & Low Drawdown Trading Techniques - Newser
Why PDS Biotechnology Corporation stock attracts strong analyst attentionWeekly Profit Report & Long-Term Growth Plans - 선데이타임즈
Using Python tools to backtest PDS Biotechnology Corporation strategiesLong Setup & Weekly High Return Stock Opportunities - Newser
Statistical indicators supporting PDS Biotechnology Corporation’s strengthLayoff News & AI Based Buy and Sell Signals - Newser
Smart tools for monitoring PDS Biotechnology Corporation’s price actionWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
HC Wainwright Lifts Earnings Estimates for PDS Biotechnology - Defense World
Evaluating PDS Biotechnology Corporation with trendline analysisEarnings Overview Summary & Stock Portfolio Risk Management - Newser
Applying sector rotation models to PDS Biotechnology CorporationWall Street Watch & Long-Term Capital Growth Ideas - Newser
Using Ichimoku Cloud for PDS Biotechnology Corporation technicalsJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - Newser
Candlestick Signal Suggests Reversal in PDS Biotechnology CorporationJuly 2025 Outlook & Verified Entry Point Signals - metal.it
Is PDS Biotechnology Corporation the Top Chart Pick This WeekQuarterly Risk Review & Fast Entry High Yield Stock Tips - beatles.ru
What makes PDS Biotechnology Corporation stock price move sharplySwing Trade & Fast Gain Stock Tips - Newser
PDS Biotech plans completion of metastatic colorectal cancer cohort enrollment by Q4 2025 amid sustained trial momentum - MSN
PDS Biotechnology Corporation (NASDAQ:PDSB) Q2 2025 Earnings Call Transcript - Insider Monkey
PDS Biotechnology Corporation Sees Spike in Bullish Option FlowJuly 2025 EndofMonth & Technical Pattern Alert System - beatles.ru
Pds Biotechnology Corporation Stock (PDSB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pds Biotechnology Corporation Stock (PDSB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Glover Stephen C. | Director |
Feb 28 '25 |
Buy |
1.66 |
15,061 |
25,001 |
78,851 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):